Introduction to Personalized Medicine Part 2

The Effective Statistician - in association with PSI

Inhalt bereitgestellt von Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry, Alexander Schacht, Benjamin Piske, and Leaders in the pharma industry. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry, Alexander Schacht, Benjamin Piske, and Leaders in the pharma industry oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

2M ago 33:41

AAC•Episode-Home

Interview with Thomas Debray

Personalized medicine challenges
Developing personalized strategies
Traditional study design limitations
Crossover trials and their uniqueness
Phase three study design inadequacy
Generalizability issues
Data collection and design for individual patient benefit
Observational data and randomized trials
Leveraging existing data sources
Importance of standardization
Integrating multiple studies and data types
Future of personalized medicine in various indications

If you found this episode enlightening, we encourage you to share it with friends, colleagues, and anyone who stands to benefit from a deeper understanding of personalized medicine's potential and pitfalls.

Together, we can advance the conversation and move closer to a future where healthcare is as unique as the individuals it serves.

Interested in harnessing the power of leadership to drive meaningful impact in the realm of statistics together? Check out this program: The Effective Statistician with Leadership Program

371 Episoden

#Natural Sciences #Statistics #Biostatistics #Pharmaceutical #Benjamin Piske #Alexander Schacht #Leaders in the pharma industry #Data Science #Science #Psy